Regentis Biomaterials Ltd (RGNT)

$3.28 -0.10 (-3.10%)
Market Cap 16.96M
Revenue (ttm) 0.00
Net Income (ttm) -13.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,900
Avg Vol 22,782
Day's Range N/A - N/A
Shares Out 5.18M
Stochastic %K 19%
Beta N/A
Analysts Strong Sell
Price Target $10.00

Company Profile

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 972 9 960 1917
Address:
60, Medinat Hayehudim, Entrance C Herzlia Pituach, Herzliya, Israel
choyler97
choyler97 Mar. 11 at 5:49 PM
$RGNT Is this company and stock even alive anymore????
0 · Reply
Victory777777
Victory777777 Mar. 5 at 3:53 PM
$RGNT is the next $BNAI
0 · Reply
sneeds_feed_N_seed
sneeds_feed_N_seed Feb. 27 at 6:45 PM
$RGNT I think here is good to scale in, $6-8 again soon.(?)
0 · Reply
TheMorningStew
TheMorningStew Feb. 23 at 7:28 PM
$RGNT solid scale in range. Will get pumped back to 5-8$ eventually
0 · Reply
Victory777777
Victory777777 Feb. 23 at 1:24 PM
$NYT $RGNT
0 · Reply
Victory777777
Victory777777 Feb. 19 at 3:14 PM
$RGNT what happened to the stock?
0 · Reply
choyler97
choyler97 Feb. 17 at 9:30 PM
$RGNT So much for taking a chance.
0 · Reply
Ahirman
Ahirman Feb. 17 at 7:42 PM
$RGNT looking for a re-entry wondering if > 3 is a start. We are already 1/2 the offering price
0 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 2:38 PM
$IMTE $OLB $YCBD $RGNT [|]|]
0 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 2:18 PM
$RGNT $SOS $NCI $KNRX [][][
0 · Reply
Latest News on RGNT
Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update

Feb 24, 2026, 4:15 PM EST - 19 days ago

Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update

Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage Repair

Feb 19, 2026, 8:30 AM EST - 24 days ago

Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage Repair

Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial

Feb 4, 2026, 8:33 AM EST - 5 weeks ago

Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial

Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.

Jan 29, 2026, 8:33 AM EST - 6 weeks ago

Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

Jan 20, 2026, 8:33 AM EST - 7 weeks ago

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation

Jan 6, 2026, 8:21 AM EST - 2 months ago

Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation

Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC

Dec 18, 2025, 8:35 AM EST - 3 months ago

Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC

U.S. IPO Weekly Recap: December Kicks Off With 3 Notable Launches In A Week With 7 SPACs

Dec 6, 2025, 12:10 AM EST - 3 months ago

U.S. IPO Weekly Recap: December Kicks Off With 3 Notable Launches In A Week With 7 SPACs

CDNL LMRI MDLN MEON PARK REED ROC

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

Dec 5, 2025, 4:10 PM EST - 3 months ago

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering

Dec 3, 2025, 7:23 PM EST - 3 months ago

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering

Israeli hydrogel implant developer Regentis Biomaterials files and sets terms for a $10 million US IPO

Mar 11, 2025, 9:16 AM EDT - 1 year ago

Israeli hydrogel implant developer Regentis Biomaterials files and sets terms for a $10 million US IPO

Regentis Biomaterials IPO Registration Document (F-1)

Mar 11, 2025, 6:09 AM EDT - 1 year ago

Regentis Biomaterials IPO Registration Document (F-1)

choyler97
choyler97 Mar. 11 at 5:49 PM
$RGNT Is this company and stock even alive anymore????
0 · Reply
Victory777777
Victory777777 Mar. 5 at 3:53 PM
$RGNT is the next $BNAI
0 · Reply
sneeds_feed_N_seed
sneeds_feed_N_seed Feb. 27 at 6:45 PM
$RGNT I think here is good to scale in, $6-8 again soon.(?)
0 · Reply
TheMorningStew
TheMorningStew Feb. 23 at 7:28 PM
$RGNT solid scale in range. Will get pumped back to 5-8$ eventually
0 · Reply
Victory777777
Victory777777 Feb. 23 at 1:24 PM
$NYT $RGNT
0 · Reply
Victory777777
Victory777777 Feb. 19 at 3:14 PM
$RGNT what happened to the stock?
0 · Reply
choyler97
choyler97 Feb. 17 at 9:30 PM
$RGNT So much for taking a chance.
0 · Reply
Ahirman
Ahirman Feb. 17 at 7:42 PM
$RGNT looking for a re-entry wondering if > 3 is a start. We are already 1/2 the offering price
0 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 2:38 PM
$IMTE $OLB $YCBD $RGNT [|]|]
0 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 2:18 PM
$RGNT $SOS $NCI $KNRX [][][
0 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 2:17 PM
$ETOR $IBG $RGNT $KLRS ~||~
0 · Reply
PortfolioQuintessence
PortfolioQuintessence Feb. 17 at 1:16 PM
$RGNT Obscure micro-cap; minimal information.
0 · Reply
Ahirman
Ahirman Feb. 10 at 9:36 PM
$RGNT a shame the CFO hire and promoting in Europe pharma market didn't at least stop the decline to trade sideways. Just constant down at the moment. Going to cut losses here and come back at 2-3 range. Maybe everyone is expecting the next move is a share offering
0 · Reply
choyler97
choyler97 Feb. 10 at 5:22 PM
$RGNT This has been a disappointment......
1 · Reply
Guitars7
Guitars7 Feb. 9 at 6:06 PM
$RGNT What was the reason for sharp drop early February?
0 · Reply
ZenithYield
ZenithYield Feb. 9 at 3:17 PM
$RGNT Regenerative medicine or biotech; field is promising but commercially unproven.
0 · Reply
Victory777777
Victory777777 Feb. 5 at 8:14 PM
$KELYB $RGNT
0 · Reply
Ahirman
Ahirman Feb. 4 at 9:57 PM
$RGNT Regentis Biomaterials Ltd. Announces the Appointment of Ori Gon as Chief Financial Officer, Effective February 4, 2026
0 · Reply
Bullrun49
Bullrun49 Feb. 3 at 7:58 PM
$RGNT Best to get in at 1
0 · Reply
Ahirman
Ahirman Jan. 29 at 8:46 PM
$RGNT https://finance.yahoo.com/news/regentis-expanding-pivotal-phase-iii-133300657.html
0 · Reply
Ahirman
Ahirman Jan. 29 at 5:26 PM
$RGNT currently on yahoo finance that is no joke of a purchase
0 · Reply
Leoheart
Leoheart Jan. 29 at 12:14 AM
$RGNT $1000 coming in tomorrow. Loading up more ^_^ loveling it . Lower it goes cheaper it is and more shares let’s go.
1 · Reply